Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge.
Hulshof AM, Braeken DCW, Ghossein-Doha C, van Santen S, Sels JEM, Kuiper GJAJM, van der Horst ICC, Ten Cate H, van Bussel BCT, Olie RH, Henskens YMC.
Hulshof AM, et al. Among authors: braeken dcw.
Res Pract Thromb Haemost. 2021 Sep 24;5(6):e12579. doi: 10.1002/rth2.12579. eCollection 2021 Aug.
Res Pract Thromb Haemost. 2021.
PMID: 34595368
Free PMC article.
BACKGROUND: The prothrombotic phenotype has been extensively described in patients with acute coronavirus disease 2019 (COVID-19). However, potential long-term hemostatic abnormalities are unknown. OBJECTIVE: To evaluate the changes in routine hemostasis laboratory paramet …
BACKGROUND: The prothrombotic phenotype has been extensively described in patients with acute coronavirus disease 2019 (COVID-19). However, …